Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cardiff, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Viracta Therapeutics, Inc. has filed 1,181 SEC EDGAR filings since 07 Aug 2002

SEC filing history

Showing 1-25 of 861 matching filings.

Per page
25
Current page
1
25-NSE File 000-51531

25-NSE filing

Filing date
10 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-81034

SCHEDULE 13G filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
27 Nov 2024
Reporting date
25 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
27 Nov 2024
Reporting date
25 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

AMENDMENT NO. 10 TO SCHEDULE 13G

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Sep 2024
Reporting date
25 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Sep 2024
Reporting date
25 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
24 Jun 2024
Reporting date
20 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
24 Jun 2024
Reporting date
20 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
24 Jun 2024
Reporting date
20 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
24 Jun 2024
Reporting date
20 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
24 Jun 2024
Reporting date
20 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .